Brief: Arch Biopartners provides update on GMP manufacturing of AB569
27/07/2017 17:43
July 27 (Reuters) - Arch Biopartners Inc ARCH.V :
* Arch Biopartners provides update on GMP manufacturing of
AB569
* Says manufacturing of AB569 on schedule
Source text for Eikon: ID:nCCNjq7vha
Further company coverage: ARCH.V
((Bangalore.newsroom@thomsonreuters.com;;))
Recent news on Arch Biopartners
See all newsBrief: Arch Biopartners To Expand Phase Ii Cardiac Surgery-Associated Acute Kidney Injury Trial To The US
Brief: Arch Biopartners Closes Non-Brokered Private Placement
Brief: Arch Strengthens Its Position As A Leading Kidney Therapeutics Company With The Acquisition Of A Breakthrough Platform To Develop New Drugs Targeting Chronic Kidney Disease (Ckd)
Brief: Arch Biopartners Closes Non-Brokered Private Placement
Brief: Arch Biopartners Announces Ontario Research Ethics Board Approval To Start Phase II Trial For LSALT Peptide